DE2127393C3 - Hepta- und Octapeptide - Google Patents

Hepta- und Octapeptide

Info

Publication number
DE2127393C3
DE2127393C3 DE2127393A DE2127393A DE2127393C3 DE 2127393 C3 DE2127393 C3 DE 2127393C3 DE 2127393 A DE2127393 A DE 2127393A DE 2127393 A DE2127393 A DE 2127393A DE 2127393 C3 DE2127393 C3 DE 2127393C3
Authority
DE
Germany
Prior art keywords
vai
asn
boc
resin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2127393A
Other languages
German (de)
English (en)
Other versions
DE2127393B2 (de
DE2127393A1 (de
Inventor
George Smith Norwich Denning Jun.
Donald Theodore Oxford Pals
Frank East Brunswick N.J. Sipos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co Norwich Ny (vsta)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co Norwich Ny (vsta) filed Critical Norwich Pharmacal Co Norwich Ny (vsta)
Publication of DE2127393A1 publication Critical patent/DE2127393A1/de
Publication of DE2127393B2 publication Critical patent/DE2127393B2/de
Application granted granted Critical
Publication of DE2127393C3 publication Critical patent/DE2127393C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2127393A 1971-02-12 1971-06-02 Hepta- und Octapeptide Expired DE2127393C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11504571A 1971-02-12 1971-02-12

Publications (3)

Publication Number Publication Date
DE2127393A1 DE2127393A1 (de) 1972-09-07
DE2127393B2 DE2127393B2 (de) 1979-09-20
DE2127393C3 true DE2127393C3 (de) 1980-07-10

Family

ID=22358997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2127393A Expired DE2127393C3 (de) 1971-02-12 1971-06-02 Hepta- und Octapeptide

Country Status (8)

Country Link
US (1) US3751404A (OSRAM)
JP (1) JPS5414103B1 (OSRAM)
AT (1) AT333986B (OSRAM)
DE (1) DE2127393C3 (OSRAM)
ES (1) ES391701A1 (OSRAM)
FR (1) FR2125248B1 (OSRAM)
IL (1) IL36869A (OSRAM)
PH (3) PH13821A (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907762A (en) * 1971-12-27 1975-09-23 Univ Sherbrooke Angiotensin{hd II {B position 8 analogs
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2
HU191961B (en) * 1984-08-02 1987-04-28 Richter Gedeon Vegyeszet Process for producing 1,5 and 8 substituted peptides of angiotenzin-ii antagonistic activity
AU7034791A (en) * 1989-12-29 1991-07-24 University Technologies International Inc. Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
ZA9010460B (en) * 1989-12-29 1992-11-25 Univ Technologies Int Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
HUE026131T2 (en) 2008-12-29 2016-05-30 Trevena Inc Beta-arresin effector and preparations and methods for their use
CA2938986A1 (en) 2014-02-07 2015-08-13 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
JP7026575B2 (ja) 2018-05-22 2022-02-28 株式会社ニューフレアテクノロジー 電子ビーム照射方法、電子ビーム照射装置、及びプログラム

Also Published As

Publication number Publication date
US3751404A (en) 1973-08-07
FR2125248A1 (OSRAM) 1972-09-29
DE2127393B2 (de) 1979-09-20
IL36869A0 (en) 1971-07-28
PH17100A (en) 1984-05-29
JPS5414103B1 (OSRAM) 1979-06-05
ATA483471A (de) 1976-04-15
PH17092A (en) 1984-05-29
ES391701A1 (es) 1973-06-16
AT333986B (de) 1976-12-27
DE2127393A1 (de) 1972-09-07
IL36869A (en) 1974-11-29
FR2125248B1 (OSRAM) 1975-08-01
PH13821A (en) 1980-10-03

Similar Documents

Publication Publication Date Title
EP0034259B1 (de) Peptidester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel beziehungsweise Diagnostica
DE69212011T2 (de) Endothelin Antagoniste
DE602004001727T2 (de) Verfahren zur herstellung cyclischer peptide
DD154098A5 (de) Verfahren zur herstellung neuer acylpeptide
DE69013742T2 (de) Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia.
DE2127393B2 (de) Hepta- und Octapeptide
AT394727B (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
DE2831534C2 (de) Octapeptide, Verfahren zu ihrer Herstellung und diese Octapeptide enthaltende Angiotensin-II-antagonistisch wirkende Arzneimittel
DE2324239C3 (de) Verfahren zur Herstellung von Asparaginylgruppen enthaltenden biologisch aktiven Polypeptiden
DE2831271C2 (de) Heptapeptide, Verfahren zu ihrer Herstellung und diese Heptapeptide enthaltende, angiotensin-II-antagonistisch wirkende Arzneimittel
DE3314357A1 (de) Vasopressin-analoga, ihre herstellung und pharmazeutische mittel
EP0003028B1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
CH658661A5 (de) Peptidverbindungen.
DE2311786C2 (de) Verfahren zur Herstellung von Peptiden
DE2754770C2 (de) N-Acyltetrapeptidamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2341775B2 (de) In Nterminaler Stellung den Rest einer Aminooxysäure aufweisende Peptide mit ACTH-Wirkung, Verfahren zu ihrer Herstellung sowie diese Peptide enthaltende Arzneimittel
DE1941511C2 (de) Calcitonin-Analoga und ihre α-Desamino- und N↑α↑-Acylaminoderivate, diese Peptide enthaltende pharmazeutische Präparate, und synthetische Verfahren zu ihrer Herstellung sowie zur Herstellung von Calcitonin M
DE2305727A1 (de) Pentapeptide und ihre verwendung als psychopharmaka
DE2010759C3 (de) Eckige Klammer auf beta- Ala hoch 1- eckige Klammer zu -ACTH (1- 18>NH tief 2, seine Salze mit Säuren und Komplexe mit Schwermetallen und Polyaminosäuren, sowe diese Verbindungen enthaltende Arzneimittel
EP0412508B1 (de) Vasopressin-Analoga,ihre Herstellung und ihre pharmazeutische Verwendung
DE1493559C3 (de) Neue Peptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung
DD140877A1 (de) Verfahren zur herstellung von sarcosylheptapeptiden
DD157095A1 (de) Verfahren zur herstellung von beta-casomorphin-5 und hoch 14 c-bzw.hoch 3 m-markierten beta-casomorphin-5
CH494740A (de) Verfahren zur Herstellung bisher unbekannter Polypeptide
DE1800129B2 (de) Biologisch aktive Polypeptide und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8327 Change in the person/name/address of the patent owner

Owner name: NORWICH EATON PHARMACEUTICALS, INC., 13815 NORWICH

8328 Change in the person/name/address of the agent

Free format text: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DIPL.-CHEM. DR.RER.NAT. BEHRENS, D., DR.-ING. GOETZ, R., DIPL.-ING. DIPL.-WIRTSCH.-ING., PAT.-ANW., 8000 MUENCHEN